IRIS Accounts Production v24.3.0.553 14709352 Board of Directors 6.3.23 31.3.24 31.3.24 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 Ordinary C 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh147093522023-03-05147093522024-03-31147093522023-03-062024-03-31147093522023-03-0514709352ns15:EnglandWales2023-03-062024-03-3114709352ns14:PoundSterling2023-03-062024-03-3114709352ns10:Director12023-03-062024-03-3114709352ns10:PrivateLimitedCompanyLtd2023-03-062024-03-3114709352ns10:SmallEntities2023-03-062024-03-3114709352ns10:AuditExempt-NoAccountantsReport2023-03-062024-03-3114709352ns10:SmallCompaniesRegimeForDirectorsReport2023-03-062024-03-3114709352ns10:SmallCompaniesRegimeForAccounts2023-03-062024-03-3114709352ns10:FullAccounts2023-03-062024-03-3114709352ns10:OrdinaryShareClass12023-03-062024-03-3114709352ns10:OrdinaryShareClass22023-03-062024-03-3114709352ns10:OrdinaryShareClass32023-03-062024-03-3114709352ns10:Director22023-03-062024-03-3114709352ns10:RegisteredOffice2023-03-062024-03-3114709352ns5:CurrentFinancialInstruments2024-03-3114709352ns5:ShareCapital2024-03-3114709352ns5:RetainedEarningsAccumulatedLosses2024-03-3114709352ns10:OrdinaryShareClass12024-03-3114709352ns10:OrdinaryShareClass22024-03-3114709352ns10:OrdinaryShareClass32024-03-31
REGISTERED NUMBER: 14709352 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE PERIOD 6 MARCH 2023 TO 31 MARCH 2024

FOR

NEXT GENERATION SURGERY LIMITED

NEXT GENERATION SURGERY LIMITED (REGISTERED NUMBER: 14709352)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE PERIOD 6 MARCH 2023 TO 31 MARCH 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


NEXT GENERATION SURGERY LIMITED

COMPANY INFORMATION
FOR THE PERIOD 6 MARCH 2023 TO 31 MARCH 2024







DIRECTORS: M Tutton
S P Sharif





REGISTERED OFFICE: 2nd Floor
Medway Bridge House
1 - 8 Fairmeadow
Maidstone
Kent
ME14 1JP





REGISTERED NUMBER: 14709352 (England and Wales)





ACCOUNTANTS: Crowe U.K. LLP
2nd Floor
Medway Bridge House
1-8 Fairmeadow
Maidstone
Kent
ME14 1JP

NEXT GENERATION SURGERY LIMITED (REGISTERED NUMBER: 14709352)

BALANCE SHEET
31 MARCH 2024

Notes £   
CURRENT ASSETS
Debtors 4 7,256
Cash at bank and in hand 12,493
19,749
CREDITORS
Amounts falling due within one year 5 14,433
NET CURRENT ASSETS 5,316
TOTAL ASSETS LESS CURRENT LIABILITIES 5,316

CAPITAL AND RESERVES
Called up share capital 6 400
Retained earnings 4,916
SHAREHOLDERS' FUNDS 5,316

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 24 November 2024 and were signed on its behalf by:





M Tutton - Director


NEXT GENERATION SURGERY LIMITED (REGISTERED NUMBER: 14709352)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD 6 MARCH 2023 TO 31 MARCH 2024


1. STATUTORY INFORMATION

Next Generation Surgery Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Going concern
Accounting standards require the directors to consider the appropriateness of the going concern basis when preparing the financial statements. The directors confirm that they consider that the going concern basis remains appropriate. The directors believe that the company has sufficient resources to continue in operational existence for the foreseeable future. The directors believe this to be the case as the company has positive reserves, cash balances and no significant long term liabilities.

Thus, they continue to adopt the going concern basis of accounting in preparing the annual financial statements.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Financial instruments
The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable, loans from banks and other third parties, loans to related parties and investments in non-puttable ordinary shares.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Debtors
Short term debtors are measured at transaction price, less any impairment.

Creditors
Short term creditors are measured at the transaction price.

NEXT GENERATION SURGERY LIMITED (REGISTERED NUMBER: 14709352)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 6 MARCH 2023 TO 31 MARCH 2024


2. ACCOUNTING POLICIES - continued

Cash and cash equivalents
Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with no significant risk of change in value.

Financial reporting standard 102 - reduced disclosure exemptions
The company has taken advantage of the following disclosure exemptions in preparing these financial statements, as permitted by the FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland":
- the requirements of Section 7 Statement of Cash Flows;
- the requirements of Section 3 Financial Statement Presentation paragraph 3.17 (d);
- the requirements of Section 11 Financial Instruments paragraphs 11.39 to 11.48A;
- the requirements of Section 12 Other Financial Instruments paragraphs 12.26 to 12.29;
- the requirements of Section 26 Share-based Payment paragraphs 26.18(b), 26.19 to 26.21
and 26.23;
- the requirements of Section 33 Related Party Disclosures paragraph 33.7.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 2 .

4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Trade debtors 7,256

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Corporation tax 8,215
Social security and other taxes 651
Wages control 2,424
Directors' loan accounts 142
Accruals and deferred income 3,001
14,433

6. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal
value: £   
100 Ordinary A £1 100
100 Ordinary B £1 100
200 Ordinary C £1 200
400

The Ordinary A and Ordinary B shares hold the same share particulars. Each share has full rights in the company with respect to voting, dividends and distributions. The Ordinary C shares have no voting rights, but hold rights to dividends and distributions.

7. RELATED PARTY DISCLOSURES

At the balance sheet date, there is an amount owed to a Director of £142. This has been included in creditors due within one year, is interest free and has no repayment terms attached.

8. ULTIMATE CONTROLLING PARTY

The directors consider there to be no ultimate controlling party.